JBIO JBIO Deferred Offering Costs In Accounts Payable Or Accrued Expenses And Other Current Liabilities
Other financials
Where this comes from
Reported directly by JBIO in its filing.
Tagged under the XBRL concept ck0001798749:DeferredOfferingCostsInAccountsPayableOrAccruedExpensesAndOtherCurrentLiabilities.
The official record: JBIO’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about JBIO's deferred offering costs in accounts payable or accrued expenses and other current liabilities.
Connect your AI assistant and see it in context, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is JBIO's deferred offering costs in accounts payable or accrued expenses and other current liabilities?
- JBIO (JBIO) reported deferred offering costs in accounts payable or accrued expenses and other current liabilities of $1.09M in Q1 2025.